Telmisartan/hydrochlorothiazide

Telmisartan/hydrochlorothiazide
Combination of
Telmisartan	Angiotensin II receptor antagonist
Hydrochlorothiazide	Thiazide diuretic
Clinical data
MedlinePlus	a611031
Pregnancy category	AU: D US: D (Evidence of risk)
Routes of administration	Oral
ATC code	C09DA07 (WHO)
Legal status
Legal status	℞ (Prescription only)
Identifiers
PubChem (CID)	216293
KEGG	D09219^Y
(verify)

Telmisartan/hydrochlorothiazide (INNs, trade names MicardisPlus or Micardis HCT) is an antihypertensive drug combination of an angiotensin II receptor antagonist with hydrochlorothiazide,^[1]^[2] the most common diuretic to be combined with other blood pressure lowering substances.

References

Antihypertensives: agents acting on the renin–angiotensin system (C09)

ACE inhibitors ("-pril")	Sulfhydryl-containing: Captopril Rentiapril Zofenopril Dicarboxylate-containing: Enalapril^# Benazepril Cilazapril Delapril Imidapril Lisinopril (+HCT) Moexipril Perindopril (+indapamide) Quinapril (+HCT) Ramipril Spirapril Temocapril Trandolapril Phosphonate-containing: Fosinopril (+HCT) Other/ungrouped: Alacepril

AIIRAs ("-sartan")	Azilsartan Candesartan Eprosartan Fimasartan Irbesartan Losartan (+HCT) Olmesartan (+amlodipine) Tasosartan^§ Telmisartan (+HCT) Valsartan (+HCT, +amlodipine, +sacubitril)

Renin inhibitors ("-kiren")	Aliskiren (+amlodipine, +amlodipine and HCT) Remikiren^§

^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

This article is issued from Wikipedia - version of the 3/25/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.